Chargement en cours...
Construction of the optimization prognostic model based on differentially expressed immune genes of lung adenocarcinoma
BACKGROUND: Lung adenocarcinoma (LUAD) is the most common pathology subtype of lung cancer. In recent years, immunotherapy, targeted therapy and chemotherapeutics conferred a certain curative effects. However, the effect and prognosis of LUAD patients are different, and the efficacy of existing LUAD...
Enregistré dans:
| Publié dans: | BMC Cancer |
|---|---|
| Auteurs principaux: | , , , , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
BioMed Central
2021
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7923649/ https://ncbi.nlm.nih.gov/pubmed/33648465 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-021-07911-8 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|